Comparative efficacy of modified antagonist protocols combining clomiphene citrate or letrozole for ovarian stimulation in patients with normal ovarian reserve.

Front Endocrinol (Lausanne) · 2026 · PMC13160801 · PMID 42130742

Europe PMC DOI

hedged sentences

0.2790

closest p · 5.6× alpha

0.2790

boldest claim

The sentences

a positive trendP = 0.279not close (p > 0.1)

Notably, the implantation rate showed a positive trend in the LE group (43.3% vs. 36.4%, P = 0.279).

also in 6,774 other papers

an increasing trendno p-value reported

GnRH antagonist (Cetrotide, Merck Serono; 0.125–0.25 mg/day) was introduced when a leading follicle reached 12 mm or serum LH showed an increasing trend.

also in 37,718 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.